AGP Executive Report
Last update: 2 hours agoPublic Health & Access: UNICEF says over six lakh zero-dose children in India still missed routine immunisation in 2025, with conflict and trust gaps keeping coverage below pre-COVID levels. Diabetes & Obesity Generics: Sun Pharma won South Africa regulator approval to make and sell a generic semaglutide injection (Ozempic/Wegovy active ingredient), aiming to expand access for adults with inadequately controlled type 2 diabetes. Healthcare Innovation Funding: India launched Phase-III of its Biomedical Research Career Programme with Rs 1,500 crore to expand fellowships and grants and speed translation into practical healthcare. Digital Health & Wearables: Researchers unveiled a soft, adhesive hydrogel interface for long-term wearable ECG/EMG/EEG monitoring that stays stable during movement and sweating. AI Regulation: China rolled out rules to curb emotional dependency on AI companion bots, requiring distress detection, crisis intervention, and user data control. Clinical Tech Breakthrough: Shanghai’s Huashan Hospital issued the first real-world prescription for the world’s first approved implantable brain-computer interface hand-motor system after stable post-op tests. Community Wellness: Phnom Penh plans to renovate a donated Japanese-funded park into a public fitness hub with trees, seating, toilets and bins, targeting completion by late 2026/early 2027.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
